3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
41
Carcinoma, Renal Cell
31
Neoplasms
18
Kidney Neoplasms
17
Neuroendocrine Tumors
16
Neoplasm Metastasis
13
Tuberous Sclerosis
10
Prostatic Neoplasms
8
Carcinoma
8
Lymphoma, Mantle-Cell
7
Lymphoma, Large B-Cell, Diffuse
7
Hodgkin Disease
7
Glioma
7
Glioblastoma
7
Astrocytoma
7
Waldenstrom Macroglobulinemia
6
Triple Negative Breast Neoplasms
6
Recurrence
6
Lymphoma
6
Head and Neck Neoplasms
6
Stomach Neoplasms
5
Ovarian Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Neuroendocrine
5
Brain Neoplasms
5
Sezary Syndrome
4
Sarcoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Mycosis Fungoides
4
Interventions
fludarabine phosphate
5
Whole-Body Irradiation
5
Mycophenolic Acid
5
Peripheral Blood Stem Cell Transplantation
4
Cyclosporins
4
Cyclosporine
4
carmustine, poliferprosan 20 drug combination
2
Sirolimus
2
Melphalan
2
Etoposide
2
Cytarabine
2
Cyclophosphamide
2
Carmustine
2
venetoclax
1
letermovir
1
ibrutinib
1
Tacrolimus
1
Stem Cell Transplantation
1
Interleukin-15
1
Hematopoietic Stem Cell Transplantation
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Prolymphocytic, T-Cell
×
Everolimus
×
Clear all
No trials found.